Wegovy and Mounjaro in Korea: a foreigner's honest guide (2026)

Usually, yes — but only after a real consultation and only with a doctor's prescription. There's no over-the-counter GLP-1 here, and any clinic willing to hand you a pen without checking you over first is one to walk away from.

The practical reality is friendlier than that sounds. Plenty of Seoul weight clinics see international patients, post their prices in English, and can write the prescription the same day if a doctor judges you suitable. What you can't bank on is qualifying automatically, or stock always being on the shelf. Eligibility, supply, and the physician's read on your health all decide the outcome. So treat a yes as likely, not certain — and don't buy a plane ticket on the assumption that the prescription is just paperwork.

Three things do most of the pulling:

• Price. Pay cash in the US and Wegovy can run about US$1,349 a month. In Korea, a four-week supply at a clinic usually lands in the US$160–290 band, depending on dose and where you go. For a lot of people, one trip pays for itself inside two months. The Wegovy and Mounjaro cost guide runs the math.
• It's in stock. Where you live, the drug might be back-ordered, rationed, or stuck behind months of insurance back-and-forth. Korean clinics tend to have supply and a clear cash price.
• English works. Seoul's weight clinics increasingly run consultations in English, and often Japanese or Chinese too.

Cheaper doesn't mean casual, though. This is a serious prescription drug that needs a doctor watching over it. The savings are real; so is doing it properly.

Two GLP-1-class drugs run the conversation, and both are available here on prescription:

• Wegovy (semaglutide) — same active ingredient as Ozempic, but dosed and approved specifically for weight management.
• Mounjaro (tirzepatide) — a newer dual-action molecule that landed in Korea in mid-August 2025. It arrived cheaper than Wegovy — roughly 25% less — with an introductory price around ₩278,000 for a four-week starter (2.5mg) dose.

One thing to plan around: neither is covered by Korea's National Health Insurance (NHIS) for obesity, so it's out of pocket either way. You'll also hear Ozempic mentioned — same semaglutide, but labeled for type-2 diabetes. Which drug fits you (if any) is a clinical call your doctor makes from your health history, not something you pick off a menu. Don't lock onto a brand before the consultation.

Korean prescribing tracks the international eligibility criteria fairly closely. As a rule, GLP-1 obesity medication goes to adults with:

• a BMI of 30 or higher, or
• a BMI between 27 and 30 plus at least one weight-related condition — high blood pressure, type-2 diabetes, high cholesterol, sleep apnea, that kind of thing.

A doctor confirms it in person — height, weight, history, what else you're taking — and decides whether treatment is safe and sensible for you. Don't fit the criteria? A responsible clinic should turn you down. These drugs aren't for shaving off a few cosmetic kilos when you're not clinically eligible, and Korean regulators have gone public warning about exactly that kind of misuse. Walk in expecting a genuine assessment, not a stamp.

GLP-1 scripts in Korea come from weight-management, internal medicine (내과), and family medicine clinics — not cosmetic dermatology or plastic surgery offices. A good number in Seoul, a lot of them clustered around Gangnam, cater to international patients and post English prices online.

A typical visit goes:

• Consult and assessment — the doctor goes through your health, measurements, and goals, and looks for reasons you shouldn't take it.
• Prescription, if you're suitable — qualify, and you're prescribed the medication, normally a once-weekly self-injection pen.
• Dose escalation — you start low and step up over weeks to keep side effects down, which matters a lot if your trip is short.
• Storage and injection guidance — including how to keep the pens cold.

Pick carefully: a clinic seeing foreign patients should be properly licensed and, where it markets to them, registered for it. The same logic in our guide on how to check a clinic is registered for foreign patients applies here. Heads up — CareRoute's own directory covers dermatology and plastic surgery, so it doesn't list weight clinics. Use it for skin and cosmetic care, and vet any GLP-1 clinic on your own.

Prescribed a course to take with you? Sort the logistics before you fly. What follows is general pointers, not legal or medical advice — verify the specifics with the prescribing clinic, your airline, and your own country's customs and health authority:

• Keep it cold. GLP-1 pens live in the fridge (roughly 2–8°C). Most labels tolerate a stretch at room temperature, but for travel a cooler bag with ice packs is the safe move. Ask the clinic for your product's exact storage window.
• Carry it on, with the paperwork. Pens go in your hand luggage — holds can freeze — alongside your prescription and the clinic's documents. Injectables with needles usually have to be declared at security under your airline's rules.
• Personal-use amounts. A personal supply is normally treated differently from commercial import, but the limits and paperwork swing wildly by country — some want a prescription or an import permit, a few restrict these drugs outright. Check first.
• Mind the dose ramp. Since doses climb over weeks, a short trip may only cover the early phase, so talk continuity of supply through with your doctor.

Don't wing this part. Five minutes with the right authority beats having your meds pulled at the border.

GLP-1 can work well. It's also a real medical treatment with a real side-effect profile, and it does best with someone keeping an eye on it:

• Common side effects — nausea, vomiting, diarrhea, constipation — hit hardest in the first few weeks and when the dose goes up. Mostly manageable, but expect them.
• It needs follow-up. Adjusting the dose, monitoring, and handling side effects mean staying in contact with a doctor, which is harder from another country — so figure out who supervises you back home.
• It's not a one-and-done. The drug works with diet and lifestyle changes, not instead of them, and weight tends to creep back after you stop.
• There are contraindications. Some personal or family histories rule these drugs out — which is the whole reason a doctor has to screen you.

Korean regulators have warned publicly about misuse. This is here for eligible patients chasing legitimate, supervised treatment — not a nudge for anyone who isn't a fit. If you're unsure, your own doctor gets the final word.